siRNA, Anti-OXA1L, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT16180WQ-2OMe)

The product SIRGT16180WQ-2OMe is a type of small interfering RNA (siRNA) that targets OXA1L gene and regulates the expression of gene. The siRNA interferes with the expression of OXA1L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_005015.3
Alternative Names OXA1
Related Diseases Mitochondrial Metabolism Disease, Mitochondrial Disorders
Purification HPLC
Target Gene
Gene ID 5018
Uniprot ID Q15070
Sub Cat Target Species Modification Scale  
SIRGT17180WQ-2F OXA1L Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT18180WQ-2MOE OXA1L Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT16180WQ-RB OXA1L Human Ribo-modified Inquiry
SIRGT17180WQ-BB OXA1L Human Backbone-modified Inquiry

Related Products